Table 3.
T2D diagnosis and diabetes medication prescriptions within 24 months of prediabetes diagnosis.
| N=9275 | Age 12-17 N=4625 |
Age 18-21 N=4650 |
|
|---|---|---|---|
| T2D Diagnosis (excluding T2D in first 30 days after prediabetes diagnosis) | 232 (2.5%) | 110 (2.38%) | 122 (2.62%) |
| Metformin Prescribed | 401 (4.32%) | 243 (5.25%) |
158 (3.40%) |
| At Least 1 Second-line Diabetes Medication Prescribed | 66 (0.71%) | 25 (0.54%) | 41 (0.88%) |
| Insulin Prescribed | 28 (0.3%) | 14 (0.30%) | 14 (0.30%) |
| GLP-1 RA, DPP4i, or SGLTi Prescribed | 26 (0.28%) | 6 (0.13%) | 20 (0.43%) |
| Sulfonylurea, Thiazolidinedione, or Metformin Combination Therapy Prescribed | 26 (0.28%) | 5 (0.11%) | 21 (0.45%) |